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Although large-scale copy-number variation is an important contributor to conspecific genomic diversity, whether
these variants frequently contribute to human phenotype differences remains unknown. If they have few functional
consequences, then copy-number variants (CNVs) might be expected both to be distributed uniformly throughout the
human genome and to encode genes that are characteristic of the genome as a whole. We find that human CNVs are
significantly overrepresented close to telomeres and centromeres and in simple tandem repeat sequences.
Additionally, human CNVs were observed to be unusually enriched in those protein-coding genes that have
experienced significantly elevated synonymous and nonsynonymous nucleotide substitution rates, estimated between
single human and mouse orthologues. CNV genes encode disproportionately large numbers of secreted, olfactory, and
immunity proteins, although they contain fewer than expected genes associated with Mendelian disease. Despite
mouse CNVs also exhibiting a significant elevation in synonymous substitution rates, in most other respects they do
not differ significantly from the genomic background. Nevertheless, they encode proteins that are depleted in
olfactory function, and they exhibit significantly decreased amino acid sequence divergence. Natural selection appears
to have acted discriminately among human CNV genes. The significant overabundance, within human CNVs, of genes
associated with olfaction, immunity, protein secretion, and elevated coding sequence divergence, indicates that a
subset may have been retained in the human population due to the adaptive benefit of increased gene dosage. By
contrast, the functional characteristics of mouse CNVs either suggest that advantageous gene copies have been
depleted during recent selective breeding of laboratory mouse strains or suggest that they were preferentially fixed as
a consequence of the larger effective population size of wild mice. It thus appears that CNV differences among mouse
strains do not provide an appropriate model for large-scale sequence variations in the human population.
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Introduction
How much do different classes of sequence polymorphisms
contribute to human phenotypic variation and disease
susceptibility? Traditionally, because they are abundant and
easily detectable, single nucleotide polymorphisms (SNPs)
have been expected to contribute most. Larger-scale poly-
morphisms, such as duplications, deletions, translocations,
and inversions, are less frequent and thus might be thought to
have a lesser effect [1].
However, as techniques have improved for detecting poly-
morphisms at larger scales, evidence has accumulated that
these occur far more frequently than hitherto suspected.
Some disease-associated genomic rearrangements, for exam-
ple, are known to arise at least an order of magnitude more
frequently than point mutations in human autosomal dom-
inant traits [1]. Moreover, several hundred regions that are
variable in copy number have been identified in both human
populations [2–5] and mouse strains [6]. Although whether
these large-scale copy-number variants (CNVs) are associated
with disease is as yet unknown, their abundance and size imply
that they may yet be found to underlie functional variation.
Nonetheless, relatively few of the human CNVs detected thus
far in independent studies overlap [7], indicating that,
although numerous, individual CNVs may occur with low
minor allele frequencies in the human population.
Sequence variations are usually not uniformly distributed
within genomes. In yeast, SNPs are more frequent towards
telomeric chromosomal ends [8], as are segmental duplica-
tions [9,10], but not apparently CNVs in human DNA [5]. SNPs
also occur more frequently within a sequence that is high in G
þ C content, that has experienced elevated nucleotide
substitution rates, and/or that has been subject to reduced
selective constraints [11,12]. Consequently, it appears that
SNPs have both arisen by mutation and been purified by
natural selection, nonuniformly in the human genome.
The assembled human genome sequence is a composite
since it is derived from the DNA of many individuals. For any
region there is no guarantee that it presents the major allele
found in a human population. Indeed, there are three reasons
to suppose that rare large-scale sequence variations such as
CNVs are not only present, but are overrepresented, in this
reference sequence. First, contributing genomes that have
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been sequenced across boundaries between adjoining paral-
ogous CNV sequences will be favoured for incorporation in
the assembly. Second, clone selection for sequencing was
biased towards larger insert clones because of the desirability
of constructing a minimal tiling set [13]. As a result, clones
containing high copy-number regions would be preferred for
sequencing over those containing low copy-number regions.
Third, because human CNVs, genome assembly gaps, and
segmental duplications frequently coincide [2,3,4,5,14], it is
plausible that minor allele sequences might be confounding
sequence assembly of these regions. We thus predict that an
as-yet-unknown proportion of the 5% of the human genome
that is highly sequence similar [3,14–16] represents minor
allele frequency CNV sequence. It remains to be determined
how this 5% partitions between duplications that have been
fixed, and thus are present throughout the human popula-
tion, and others that are polymorphic and are not fixed.
The presence of large-scale minor allelic variants in the
reference human genome sequence complicates both CNV
experimental design and CNV data interpretation. For
example, virtually identical paralogous human sequences
are substantially underrepresented in oligonucleotide arrays,
thus diminishing the distinction of their copy-number
variations in experiments. Furthermore, hybridisation absen-
ces may be interpreted as genomic deletions, whereas instead
they arise from assaying for minor allelic variants in the
reference sequence.
Some CNVs may have been maintained in a subset of the
human population due to selective advantage [17], partic-
ularly those present at relatively high minor allele frequency.
For example, unusually high copy numbers of the CCL3L1
and CYP2D6 genes are associated with decreased suscepti-
bility to HIV/AIDS [18] and increased drug metabolism [19],
respectively. However, their frequencies suggest that most
CNVs have been subject to purifying selection [3].
The fate of CNVs—either fixation or else loss by purifying
selection or drift—has been considered theoretically for
many decades [17]. Wright’s physiological theory [20] predicts
that haploinsufficient genes (i.e., those whose loss-of-function
alleles strongly affect the phenotype of heterozygotes)
experience enhanced fixation of duplicates resulting from
selection for increased dosage. Such genes preferentially
encode proteins with signalling roles or with binding,
regulatory, and structural functions [21,22]. Selective advant-
age of duplicates due to gene dosage appears to have
occurred, for example, for CCL3L1 [18] and CYP2D6 [19].
The neutral theory of molecular evolution [23] predicts
that a duplicated gene is more rapidly lost by random genetic
drift when it arises within larger populations [24,25]. In very
large populations virtually all duplications that are rapidly
fixed are thus strongly adaptive. By contrast, very small
populations are more heterozygous with larger proportions
of neutral, slightly advantageous, or disadvantageous dupli-
cates persisting [24].
We were interested in investigating whether CNVs occur
preferentially within particular sites and types of human
sequence and whether neutral, purifying, or diversifying
selection has acted upon them. Our null hypothesis is that
CNVs arise uniformly in a genome and are selectively neutral.
In this model we expect CNVs not to be enriched in protein-
coding genes or other evolutionary, structural, and functional
characteristics. To test the model, we surveyed 13 different
properties relating to CNVs and CNV genes of human and
mouse, and compared these to their genome-wide distribu-
tions. Our study relies on recent surveys of CNVs, in particular
those of Sebat et al. [3], Iafrate et al. [2], Tuzun et al. [4], and
Sharp et al. [5]. We assume that these CNVs have been sampled
uniformly from those present in the human population.
We tested whether CNVs occur more frequently, like
synonymous substitutions [26], close to telomeres or to
pericentromeres, whether they contain unusually high den-
sities of genes, repeats, or G þ C base content. We also
examined the relative evolutionary rates of CNV genes and
their functions. We find that CNVs occur more frequently
towards telomeres and centromeres, are enriched in protein-
coding genes and simple tandem repeats, but are not elevated
in G þ C content. Human CNV genes have experienced
elevated synonymous and nonsynonymous nucleotide substi-
tution rates, have a deficit ofMendelian disease genes, and have
a surfeit of genes encoding secreted and immunity proteins.
Mouse CNVs, on the other hand, possess significantly fewer
of the genes that are overrepresented in human CNVs,
although they demonstrate the same significant elevation in
synonymous nucleotide substitution rates seen for human
CNVs. These results indicate that natural selection has acted
nonrandomly upon CNVs. We suggest that the different
characteristics of human and mouse CNVs we observe may be
consequences of these species’ contrasting effective popula-
tion sizes.
Results
CNV Properties Relative to Those for the Human Genome
Known human CNVs are neither significantly overpopu-
lated nor underpopulated in densities of RNA genes,
interspersed repeats (either considered together, or short or
long interspersed nuclear elements considered separately),
CpG islands, or GþC content relative to the whole genome (p
. 0.05). The apparent lack of bias of interspersed repeats and
Gþ C content within CNVs, relative to the remainder of the
genome, argues that our conclusions (below) should not be
adversely affected by sequence-dependent variations in
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Synopsis
Until recently, it was thought that most inherited human diversity
results from genetic variation at single nucleotide sites. However,
recent studies discovered many larger-scale differences, involving
the duplication or deletion of thousands of bases. Do these large-
scale differences contribute greatly to characteristics of human
individuals, or are they of little consequence? For clues to solve this
mystery the authors looked to the signatures of adaptive evolution
written into the DNA. They reasoned that if large-scale DNA
differences are beneficial, they should be enriched in genes,
particularly those involved in fighting infection and sensing our
environment. The authors discovered such enrichments indicating
that some large-scale sequence differences have been advanta-
geous during the last approximately 100,000 y of human history. By
contrast, modern laboratory mice exhibit few signs of beneficial
large-scale DNA differences, perhaps because advantageous se-
quences have swept rapidly through their ancestral populations.
Some large-scale variations in human genomes thus appear to be a
legacy of past evolutionary challenges to our species.
hybridisation signals [27]. Tissue-specific genes (see Materials
and Methods) are also not significantly (p . 0.05) over- or
underrepresented in CNVs, and no single tissue possessed
unusually high or low numbers of CNV genes expressed in
that tissue.
By way of contrast, several properties of CNVs are
significantly different (p , 0.05) from the genome as a whole
(Table 1).
First, human CNVs are significantly overrepresented in
number within 2 Mb of telomeres and centromeres (p, 105).
By comparing the distributions of CNV distances, either to
chromosomal ends or to centromeres, with randomised
distributions, we found that regions proximal to telomeres
and centromeres contain significantly more CNVs than
expected by chance (Figure 1). This observation contrasts
with a previous report that these regions are not over-
represented in CNVs [5].
Second, we found that the rates of synonymous substitution
(KS values) for genes within CNVs (median KS ¼ 0.653) are
significantly higher (p ¼ 1.5 3 103) than those for non-CNV
genes (median KS ¼ 0.593). As KS values are known to be
elevated in regions approaching telomeres [26], which are
also overrepresented in CNVs (this report), we considered
that these two observations might be causally connected.
Nevertheless, the significant elevation in KS persisted even
when CNVs within 2 Mb from a telomeric end were
discounted (p¼ 1.63 102). We could also discount that high
KS values in CNVs are associated with high G þ C or CpG
content, since each of these quantities was not significantly
different from the genome as a whole (see above).
Third, simple tandem repeats [28], which include micro-
satellites, but not other repeat types, were also found to be
significantly enriched within human CNVs (p , 7.4 3 103).
This enrichment is specific to CNVs within 2 Mb of telomeres
and centromeres, because when such CNVs were discounted
simple tandem repeats were significantly underrepresented
(p ¼ 0.04).
Bias of Selection within Human CNV Genes
Human CNVs are also significantly enriched in genes.
Those studied here contain 837 complete Ensembl genes.
Table 1. Significance Estimates of CNV Gene Properties
Property Human CNVs Mouse CNVs
p-Value Observed Expected p-Value Observed Expected
Protein genes " 2.4 3 103** 837 623 " 0.32* 492 473
OMIM genes # 8.9 3 103** 22 35 N/A N/A N/A
Simple tandem repeats (bp) " 7.4 3 103** 7,901,494 5,257,471 " 0.41* 1,737,598 1,749,000
Tandem paralogues " , 103** 68 32 # 5.7 3 102* 10 16
SignalPa " 2.8 3 102** 237 213 # 5.0 3 103** 91 115
Median KA / KS " 1.7 3 102** 0.112 0.094 # 3.3 3 103** 0.081 0.095
Median KS " 1.5 3 103** 0.653 0.593 " , 103** 0.694 0.587
Proximity to telomeres " , 103** N/A N/A nsb N/A N/A
Proximity to centromeres " , 103** N/A N/A nsb N/A N/A
A p-value estimates the probability that a property is uniformly distributed throughout the genome. Properties that are overrepresented within CNVs are indicated with an upwards arrow ("), whereas those that are
underrepresented are indicated with a downwards arrow (#). Mean values of these properties are shown, except for KA/KS and KS whose median values are shown. The 627 human CNV regions span 98,125,520 bp, whereas
the 346 CNV BACs span 55,998,000 bp.
aProteins either partially or entirely encoded within CNVs predicted by the SignalP algorithm to be secreted.
bMouse CNV genes were not overrepresented in regions approaching telomeres; no significance estimate was determined as the CNV genes’ distances to telomeric ends did not approximate to a Gaussian distribution.
*p . 0.05, **p , 0.05.
OMIM, Online Mendelian Inheritance in Man; N/A, not applicable; ns, not significant.
DOI: 10.1371/journal.pgen.0020020.t001
Figure 1. Relative Frequency Histograms of Distances from Human CNVs
to the Nearest Centromere or Telomere
Relative frequency histograms (striped blue bars) are compared to their
expected distributions if CNVs were distributed randomly within the
genome (grey bars); these expected distributions are fitted to Gaussian
distributions (grey lines). Red lines represent 99.9999% prediction
confidence intervals from the fitted curves.
DOI: 10.1371/journal.pgen.0020020.g001
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This number is a third higher than expected since, on
average, only 624 complete genes were found in each of
10,000 sets of nonoverlapping fragments randomly selected
from the human genome, each identical to the CNV set in size
distribution. It is also a significantly elevated number since in
only 0.24% of randomisations were the gene counts greater
than or equal to that of the CNV set (i.e., p ¼ 2.4 3 103).
Tandem duplications occur frequently in the mosaic refer-
ence human genome assembly [14], and a subset of these may
be polymorphic in copy number. Thus, it was not surprising
that human CNVs are also significantly enriched in paralo-
gous genes (p , 0.001).
Not all gene types, however, are overabundant within
CNVs. Genes that are both associated with Mendelian disease
and completely contained within human CNVs are signifi-
cantly underrepresented (p¼ 8.93 103). Such a surfeit could
have arisen if null alleles of haploinsufficient genes were
more frequently compensated by sequence-similar pa-
ralogues, and thus more rarely result in pathology than other
genes. This hypothesis predicts that CNV sequences have
been purified of fewer mutations than elsewhere in the
genome. We do indeed find that SNPs are significantly
overrepresented within human CNVs (p , 0.001). However,
this enrichment may in part be due to an ascertainment bias
resulting from difficulties in disambiguating allelic variants
(polymorphisms) from close paralogues’ sequence differences
(cis-morphisms) [29].
Using Gene Ontology [30] terms, we also determined that
genes involved in acquired immunity, innate immunity, or
olfaction are significantly overrepresented (p , 0.001) within
human CNVs, along with genes encoding integral membrane
proteins. Genes encoding intracellular proteins are signifi-
cantly underrepresented (see Table 2).
These findings broadly correspond with expectations from
Wright’s physiological theory [20] that duplications of
haploinsufficient genes improve fitness through selection on
increased dosage effects. Haploinsufficient genes are known
to be more likely involved in cellular regulation and
structure, signal transduction, and various binding functions
than are haplosufficient genes [22]. Notwithstanding the
underrepresentation of binding proteins, it is notable that
several GO terms relating to these functions (for example,
intermediate filament, signal transduction, and transmem-
brane receptors) are overrepresented among CNV genes.
Previous comparisons of mammalian sequences indicate
that genes whose functional categories we find to be
overrepresented in CNVs (Table 2) frequently have dupli-
cated and/or evolved adaptively, due to competition between
individuals or between host and parasite or pathogen
[12,31,32]. We can interpret these results (see Discussion) as
being consistent with positive selection having acted on some
CNV genes within the history of modern humans (approx-
imately last 100,000 y). If so, we might expect CNV genes, on
average, to have also accumulated an unusually high number
of amino acid-changing (nonsynonymous) substitutions com-
pared with silent (synonymous) substitutions over a much
longer time period, the 75–100 million y that separate the
mouse and human from their last common ancestor. In other
words, they should exhibit an elevation in the average KA/KS
ratio—the number of nonsynonymous substitutions per
nonsynonymous site (KA) relative to the number of synon-
ymous substitutions per synonymous site (KS) [33]—calculated
between human and mouse 1:1 orthologues. (Note that only
1:1 orthologues were analysed in order to ensure that lineage-
specific paralogues, which often increase their evolutionary
rates following duplication [34], do not contribute to the KA/
KS distribution.) Indeed, this is the case. Human CNV genes
possess, on average, significantly (p¼ 1.73 102) higher KA/KS
ratios than those of all 1:1 orthologue pairs (Figure 2). This
finding demonstrates that a typical human CNV gene product
and its mouse 1:1 orthologue have, on average, diverged
unusually rapidly since their common ancestor.
In addition to adaptive evolution, KA/KS ratio elevations
could also have arisen from recent relaxation of constraints
for many genes. However, the only gene family to have
suffered numerous and extensive disruptions of coding
sequence during primate evolution is the olfactory receptor
Table 2. Statistically Significant (p , 103) Over- or Under-
Representation of Gene Ontology (GO) Categories in Human
CNVs
GO ID Representation p-Value Description
0005622 Under 1.6 3 105 Intracellulara
0005634 Under 1.0 3 105 Nucleusa
0008152 Under 3.9 3 104 Metabolisma
0009605 Over 1.2 3 105 Response to external stimulusa
0009607 Over 1.9 3 104 Response to biotic stimulusa,c
0005488 Under 6.2 3 107 Bindinga
0004872 Over 2.5 3 106 Receptor activitya
0031224 Over 2.3 3 104 Intrinsic to membraneb
0016021 Over 2.1 3 104 Integral to membraneb
0005882 Over 5.6 3 104 Intermediate filamentb
0045111 Over 5.6 3 104 Intermediate filament cytoskeletonb
0043229 Under 5.9 3 106 Intracellular organelleb
0043226 Under 5.9 3 106 Organelleb
0006955 Over 5.2 3 104 Immune responseb,c
0042742 Over 1.1 3 108 Defence response to bacteriab
0007606 Over 7.9 3 1011
Sensory perception of
chemical stimulusb
0050877 Over 1.3 3 104 Neurophysiological processb
0009987 Under 5.8 3 1011 Cellular processb
0007600 Over 4.4 3 105 Sensory perceptionb
0030102 Over 8.5 3 105
Negative regulation of
natural killer cell activityb
0007608 Over 1.1 3 1011 Perception of smellb
0050874 Over 3.8 3 107 Organismal physiological processb,c
0009581 Over 3.9 3 105 Detection of external stimulusb
0009617 Over 2.6 3 107 Response to bacteriab
0050896 Over 2.6 3 106 Response to stimulusb,c
0044237 Under 2.0 3 105 Cellular metabolismb
0045845 Over 8.5 3 105
Regulation of natural
killer cell activityb
0007166 Over 9.3 3 106
Cell surface receptor-linked
signal transductionb
0050875 Under 4.6 3 1014 Cellular physiological processb
0006952 Over 1.4 3 105 Defence responseb,c
0003823 Over 3.2 3 1011 Antigen bindingb,c
0004888 Over 9.5 3 109 Transmembrane receptor activityb
0005395 Over 8.0 3 1012
Eye-pigment precursor
transporter activityb
0004984 Over 1.5 3 1011 Olfactory receptor activityb
0016160 Over 6.1 3 106 Amylase activityb
The number of GO Slim terms associated with human CNV genes was 48.
aGO Slim terms, which represent a high-level view of all GO terms.
bFull GO terms.
cGO terms associated with immunoglobulin genes whose copy-number polymorphisms may be somatic,
rather than germ-line.
DOI: 10.1371/journal.pgen.0020020.t002
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gene family [14,35]. When such genes are discarded from our
CNV gene dataset, the KA/KS ratio elevation remains
significant (p ¼ 1.5 3 102). It is thus likely that the KA/KS
ratio elevation for CNV genes indicates that they have
experienced an unusually large number of adaptive evolu-
tionary events in the past 75–100 million y. This conclusion is
consistent with previous reports that segmental duplications
contain rapidly evolving gene duplicates [14,15].
Frequencies of Observed CNVs. Gains and Losses
CNV alleles that are beneficial to human individuals should
be segregating at higher frequencies in the general popula-
tion than neutral CNV alleles, and thus should be observed in
a greater number of studies. To examine this expectation, we
partitioned our CNVs into those that have been observed in
two or more studies and those that have been observed once
only. We found that CNVs observed in multiple studies
exhibited significantly higher protein-coding genes and
simple repeat densities, and higher KA/KS values, on average
(Table 3). By way of contrast, CNVs observed in only one
study (86% of the total) exhibited none of these significant
biases (Table 3). These results are consistent with high-
frequency CNVs being preferentially retained in the human
population due to their adaptive benefit. We also note that if,
as might be expected, the set of rarer CNVs contains a greater
proportion of misassignments (experimental errors), then the
biases in CNV properties summarised in Table 1 will have
been underestimated.
We also partitioned our human CNV set into those
involving duplications (‘‘gains’’) or deletions (‘‘losses’’). (As
discussed in the Introduction, some of the high-frequency-
loss CNVs will instead represent major, rather than minor,
alleles and, thus, will not be true deletions.) We find a
significant deficit of Online Mendelian Inheritance in Man
disease genes among human gain CNVs but not among loss
CNVs (Table 4) as expected if sequence-similar paralogues
frequently functionally compensate for null alleles (see
above). This deficit may, in part, be due to reduced statistical
power to detect significant differences. We also find that loss
CNVs do not, on average, possess elevated KA/KS values
between 1:1 orthologues (Table 4), which is consistent with
duplication, and not deletion, events having provided the
substrates of positive selection.
Analyses of Mouse CNVs
We obtained 346 bacterial artificial chromosomes (BACs)
containing CNVs among inbred mouse strains [6] that were
mapped to 56 Mb of the mouse genome assembly (National
Center for Biotechnology Information Build 30). These data
presented us with the first opportunity to compare the
sequence, evolution, and function of CNV genes in two
mammalian species. Strikingly, the only quantity that differed
significantly from the genomic background in each of the two
species was KS, calculated between mouse and human 1:1
orthologues (Table 1).
Relative to human CNVs, we find that the set of mouse
CNVs analysed better characterises the null hypothesis of
random distributions both in the genome and among genes.
Mouse CNVs are not significantly enriched in protein-coding
genes, paralogous genes, simple tandem repeats, G þ C
content, or tissue-specific genes (p. 0.05) (Table 1). They also
exhibit no significant overrepresentation close to telomeres,
although this may reflect reduced coverage of BACs in these
regions.
Nevertheless, the genes encoded in mouse CNVs, and their
associated functions, are strikingly different from those in
human CNVs. In only three instances did human and mouse
1:1 orthologues overlap known CNV regions from both
species. This finding is unexpected, since the probability of
finding this number of 1:1 orthologues, or fewer, in both
human and mouse CNVs is 4 3 103. (This probability was
calculated using the hypergeometric distribution using the
observations that among approximately 13,000 human:mouse
1:1 orthologues, 418 overlap human CNVs, and 340 overlap
mouse CNVs.)
As described above, human CNV genes are enriched in
Figure 2. Relative Frequencies of the Ratio of KA to KS for Human–Mouse
1:1 Orthologous Genes
(A) KA / KS ratios for all human–mouse orthologue pairs (median KA / KS¼
0.094).
(B) KA / KS ratios for orthologue pairs of human genes that are completely
encompassed in human CNVs (median KA / KS ¼ 0.112).
(C) KA / KS ratios for orthologue pairs of mouse genes completely
encompassed in mouse CNVs (median KA / KS ¼ 0.081). A Kolmogorov-
Smirnov test between (A) and (B) demonstrates that KA / KS values are
significantly higher, on average, for human genes completely encom-
passed in human CNVs than for all human–mouse orthologue pairs (p¼
1.7 3 102). On the other hand, genes completely encompassed in
mouse CNVs exhibit significantly lower KA / KS values than all human–
mouse orthologue pairs (p ¼ 3.33 103).
DOI: 10.1371/journal.pgen.0020020.g002
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paralogous clusters of the reference genome assembly, they
possess elevated KA/KS values, and they encode signal peptide-
containing secreted proteins. However, exactly the opposite
is true for mouse CNV genes: they are typically not
overrepresented in paralogous clusters, they possess signifi-
cantly decreased KA/KS values, and they are significantly
enriched in proteins that lack signal peptides (Table 1).
Moreover, in contrast to human CNVs, for which olfactory
receptor genes are overrepresented, in mouse CNVs we find
these genes to be underrepresented (Table 5).
Only carbohydrate-binding genes are significantly (p ,
0.001) overrepresented in mouse CNV BACs. This enrich-
ment is almost entirely due to natural killer cell lectin-like
receptor Ly-49 paralogues [36]. Sequence variations between
different mouse strains have been shown to influence ligand-
binding affinities [37]. Rather than being allelic variants, as
reported previously [37], these sequence variants may thus
instead represent distinct paralogues that have segregated
differentially, as CNVs, among mouse strains since their
common origin.
Discussion
Our results are relevant to three key issues of CNV
evolution: the mutational variation of polymorphic duplica-
tion, the contribution of CNVs to phenotypic diversity and
disease, and the differences in large-scale sequence variation
between two distinct mammalian species. Each of these three
issues now will be discussed in turn.
Mutational Variation of CNVs
Both human CNV and mouse CNV sequences appear to be
unusually susceptible to synonymous nucleotide substitutions.
We assume that the nonuniform genome-wide distribution of
CNVs is due, at least in part, to variable segmental duplication
rates. Indeed, duplicates can themselves seed further duplica-
Table 3. Significance Estimates of Properties of ‘‘Frequent’’ Human CNVs Observed in Multiple Studies or ‘‘Rare’’ Human CNVs
Observed in Single Studies
Property Frequent Human CNVs Rare Human CNVs
p-Value Observed Expected p-Value Observed Expected
Protein genes " 6.1 3 103** 406 256 " 7.4 3 102* 431 368
OMIM genes # 2.1 3 102** 9 17 # 1.2 3 101* 13 18
Simple tandem repeats (bp) " 2.1 3 102** 3,591,602 1,986,000 " 5.7 3 102* 4,309,892 3,278,000
Tandem paralogues " , 103** 27 11 " , 103** 41 22
SignalPa " 9.8 3 102* 101 90 " 7.6 3 102* 136 122
Median KA / KS " 1.2 3 103** 0.130 0.095 " 2.0 3 101* 0.108 0.095
Median KS " 1.1 3 102** 0.664 0.589 " 4.4 3 102** 0.635 0.589
Proximity to telomeres " , 103** N/A N/A " , 103** N/A N/A
Proximity to centromeres " , 103** N/A N/A " , 103** N/A N/A
A p-value estimates the probability that a property is uniformly distributed throughout the genome. Properties that are overrepresented within CNVs are indicated with an upwards arrow ("), whereas those that are
underrepresented are indicated with a downwards arrow (#). Mean values of these properties are shown, except for KA/KS and KS whose median values are shown. The 85 frequent human CNV regions span 36,835,741 bp,
whereas the 542 rare human CNV regions span 61,289,779 bp.
aProteins either partially or entirely encoded within CNVs predicted by the SignalP algorithm to be secreted.
*p . 0.05, **p , 0.05.
OMIM, Online Mendelian Inheritance in Man; N/A, not applicable.
DOI: 10.1371/journal.pgen.0020020.t003
Table 4. Significance Estimates of Properties of Human CNVs Duplicated or Deleted with Respect to the Human Genome Reference
Sequence
Property Human Gain CNVs Human Loss CNVs
p-Value Observed Expected p-Value Observed Expected
Protein genes " 5.3 3 102* 578 473 " 1.1 3 102** 345 235
OMIM genes # 3.4 3 103** 12 24 # 1.2 3 101* 12 15
Simple tandem repeats (bp) " 4.2 3 102** 5,463,158 3,751,000 " 3.9 3 103** 3,961,128 1,982,000
Tandem paralogues " 1.2 3 103** 39 23 " , 103** 29 12
SignalPa " 7.8 3 102* 160 145 " 3.0 3 103** 107 85
Median KA / KS " , 103** 0.129 0.095 " 3.2 3 101* 0.107 0.095
Median KS " 2.4 3 102** 0.630 0.589 " 3.5 3 103** 0.685 0.589
Proximity to telomeres " , 103** N/A N/A " , 103** N/A N/A
Proximity to centromeres " , 103** N/A N/A " , 103** N/A N/A
A p-value estimates the probability that a property is uniformly distributed throughout the genome. Properties that are overrepresented within CNVs are indicated with an upwards arrow ("), whereas those that are
underrepresented are indicated with a downwards arrow (#). Mean values of these properties are shown, except for KA/KS and KS whose median values are shown. The 391 human CNV duplications span 72,439,353 bp,
whereas the 231 rare human CNV regions span 37,153,250 bp.
aProteins either partially or entirely encoded within CNVs predicted by the SignalP algorithm to be secreted.
*p . 0.05, **p , 0.05.
OMIM, Online Mendelian Inheritance in Man; N/A, not applicable.
DOI: 10.1371/journal.pgen.0020020.t004
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tion events by nonallelic homologous recombination [38]. It
thus appears that segmental duplication and nucleotide
substitution mutational rates are regionally correlated. Since
G þ C levels and synonymous substitution, neutral, and
recombination rates all strongly and positively covary [11], we
might expect CNV sequences to be typically associated with
high levels of recombination and G þ C content [11,39].
Nonetheless, neither human nor mouse CNVs possess atypical
GþC compositions, and human CNVs are overrepresented in
pericentromeric sequences, when these are usually charac-
terised by suppressed, rather than elevated, recombination
rates [39]. Notwithstanding the higher densities of human
CNVs close to telomeres and centromeres, and in repetitive
and high KS regions (Table 1), we find no single factor that
might explain their chromosomal distributions.
Adaptation, Phenotypic Variation, and Disease
Our results indicate that a subset of human CNVs,
particularly those found at high minor allele frequency, has
been retained in the human population as a result of positive
selection. We found that human proteins encoded within
CNVs possess, on average, unusually high KA/KS values
(measured against their single mouse orthologues) that is
consistent with a proportion of these genes having evolved
adaptively. It is notable that genes that have evolved the most
rapidly or have duplicated, when mammalian sequences are
compared [12,31,32], often correspond to those that are most
overrepresented in human CNVs. Human CNV genes possess
significant enrichments in chemosensation and immune
response functions (Table 2), which have well-documented
roles among mammals in adaptation to novel environmental
niches [31,32]. Indeed, it is only these two functions that
greatly contribute to the CNV gene KA/KS elevation because
when their associated genes (namely, those encoding olfactory
receptors, b-defensins, and immunoglobulins) are discarded,
no significant difference in KA/KS values is then observed.
Increased protein sequence divergence is also reflected in
the enrichment of paralogous genes and signal peptide-
encoding genes in human CNVs (Table 1) since each of these
categories is associated with increased protein sequence
divergence in mouse–human comparisons [12,31]. Our obser-
vation that human CNVs encode unusually high numbers of
genes may also be attributed to positive selection. We discount
an alternative hypothesis that the gene richness of CNVs is
associated with an elevated G þ C because we found no
significant differences between the GþC content distributions
of human or mouse CNVs and those of their genome
assemblies (p¼0.28 and 0.26, respectively). Instead, the elevated
gene density of CNVsmay have arisen because of the retention
of duplicated sequences that were of adaptive benefit and the
purification by selection or drift of those that were not.
The overabundance of immunity and chemosensation genes
in human CNVs implies that they might have been selectively
favoured in recent evolution. Indeed, selection on gene copy
number is reported for CCL3L1, an immune response gene,
where relatively low copy number is associated with increased
susceptibility to HIV/AIDS [18], and it remains possible that
copy-number variation of olfactory receptor genes underlies
individuals’ sensitivities to specific odorants [40,41].
An alternative hypothesis is that the unusual abundance of
‘‘environmental genes’’ within human CNVs results from
adaptation that occurred not during recent hominin evolu-
tion, as we have just proposed, but instead from earlier in the
primate lineage. In this scenario, such genes are enriched in
human CNVs simply because their forebears’ duplications
generated repetitive sequences that then have preferentially
seeded tandem duplication and CNVs by nonallelic homol-
ogous recombination. This issue remains unresolved owing to
difficulties in distinguishing mutational biases from selective
biases. Nevertheless, it would be curious if adaptive episodes
that occurred earlier in the primate lineage (and elsewhere
within the mammalian clade [12,42]) were to have discon-
tinued only in recent times. Moreover, in this study we found
no evidence that other repetitive sequences—namely, human
interspersed elements and mouse tandem paralogues—have
preferentially seeded CNV duplications. Consequently, we
believe it more likely that the biases in human CNV
properties we observe are mainly due to adaptive events in
the last 100,000 y of human history.
We found that there is a significant deficit of Mendelian
disease genes within human CNVs. From one perspective,
rather than this deficit, a surfeit might be expected. This is
because such genes in general are overrepresented in rapidly
mutating (high KS) sequence [43,44]. Nevertheless, despite
CNV sequences experiencing unusually rapid synonymous
substitution rates (see above), they contain significantly fewer
Mendelian disease genes than expected. The disease gene
deficit may thus be due in part to functional compensation
afforded by CNV paralogues.
Moreover, because tandemly repeated sequences, such as
microsatellites and paralogous genes, are a potent substrate
for human genomic rearrangement via nonallelic homologous
recombination [38], CNVs might be thought to promote
disease-associated mutations. Although such events may
occur, CNVs may also buffer the genome against deleterious
mutations if their paralogous, essentially identical, genes
compensate for one another [45]. Gene compensation,
together with the frequent lack of account taken of
polymorphic sequence-similar paralogues when candidate
disease genes are sequenced, may help to explain the under-
representation of Mendelian disease genes in CNV regions.
The Effect of Population Size on the Rate of Fixation of
CNVs
Mouse CNV genes differ from their human counterparts in
possessing significantly lower than average KA/KS values, and
Table 5. Statistically Significant (p , 103) Over- or Under-
Representation of Gene Ontology (GO) Categories in Mouse
CNVs
GO ID Representation p-Value Description
0030246 Over 5.2 3 106 Carbohydrate bindinga
0005529 Over 7.3 3 107 Sugar bindingb
0030246 Over 5.2 3 106 Carbohydrate bindingb
0004930 Under 3.3 3 104 G-protein coupled receptor activityb
0001584 Under 1.2 3 104 Rhodopsin-like receptor activityb
0004984 Under 3.5 3 104 Olfactory receptor activityb
The number of GO Slim terms associated with mouse CNV genes was 46.
aGO Slim terms, which represent a high-level view of all GO terms.
bFull GO terms.
DOI: 10.1371/journal.pgen.0020020.t005
PLoS Genetics | www.plosgenetics.org February 2006 | Volume 2 | Issue 2 | e200204
Evolution of Human and Mouse CNVs
lower fractions of signal peptide-encoding genes (Table 1).
Moreover, the number of orthologue pairs that are present in
both human CNVs and mouse CNVs is unexpectedly low, and
there are no functional categories that are overrepresented in
both species’ CNVs (Tables 2 and 5).
One explanation for these observations might be that
selection itself has acted on very different human and mouse
genes. This interpretation appears unlikely since selective
constraints on gene functions are strongly correlated when
these are compared between murids and between hominids
[46]. Other explanations might be that these results are
artifacts, arising from the different technologies and samples
used in identifying CNVs in the human population and
among mouse strains, or that the 2.4-fold fewer mouse CNVs
than human CNVs in this study results in a reduced power to
detect significant deviations. Although these remain possibil-
ities, the finding that synonymous substitutions are signifi-
cantly overrepresented in CNVs from both species and that
KA/KS values and signal peptide-encoding genes (Table 1) are
significantly lower among mouse CNV genes appear to argue
against these. A further explanation might be that selective
breeding during the recent generation of laboratory mouse
strains led to ‘‘adaptive’’ CNV gene duplicates (such as
olfactory receptor genes and genes encoding secreted
proteins) unwittingly being purged preferentially from these
lines. This final possibility will need to be investigated by
surveying CNVs from wild mice populations.
Finally, the differences between human and mouse CNV
properties may be explained if advantageous duplications
were fixed in the mouse more frequently than they were in
humans. According to the nearly neutral theory of molecular
evolution, mildly deleterious, neutral, or advantageous dupli-
cates persist for longer, on average, in smaller populations
than they do in larger populations [24,47]. For very large
effective population sizes, virtually the only gene duplications
that are fixed are those that are strongly advantageous. The
effective size of the modern human population (approx-
imately 104 [48]) is up to two orders of magnitude smaller than
that for the house mouse Mus musculus (approximately 53105
to 8 3 105 [49]). Furthermore, different laboratory mouse
strains still exhibit many of the sequence variations expected
to separate these strains’ three founder subspecies,M. musculus
subsp. musculus, M. musculus subsp. domesticus, and M. musculus
subsp. castaneus [50], indicating that, collectively, the effective
population size of laboratory mouse strains should not be
greatly reduced from that of M. musculus in the wild.
Over equivalent numbers of generations, we expect the
mouse population thus to have fixed more advantageous, and
purified more disadvantageous, mutations than the human
population. As a consequence, fewer advantageous duplica-
tions will remain as polymorphisms among extant mouse
strains compared to the human population.
This model predicts a decrease in average KA/KS values for
mouse CNV genes, when compared with their 1:1 human
orthologues, consistent with that seen in Figure 2. This is
because duplicated ‘‘adaptive’’ genes (such as those encoding
olfactory receptors and secreted proteins [31]; see Table 2)
often exhibit unusually elevated sequence divergence, and
when these are fixed in the mouse population they then
deplete the mouse KA/KS distribution of high values. A
consequence of the lower effective population size of humans
is that a greater fraction of advantageous duplications will be
fixed at essentially the same slow rate as neutral mutations.
Human CNVs are thus expected to encode disproportion-
ately large numbers of proteins that typically contribute most
to adaptation, i.e., those that are secreted and that exhibit
high sequence divergence between human and mouse [31].
The model thus accounts for both the unusually high average
human–mouse KA/KS value for human CNV genes (Figure 2)
and their enrichment in genes encoding signal peptides
(Table 1).
For the mouse this scenario predicts that genetic drift
preferentially has purged deleterious, neutral, and even
slightly adaptive duplications, whilst many strongly adaptive
duplications have been fixed at significantly increased rates
than for the human population. Future investigations of
CNVs from other species associated with contrasting effective
population sizes should help to clarify the validity of this
evolutionary model.
In summary, whereas evidence is scarce that human SNPs
have contributed frequently to adaptive evolution [12,46,51],
in human CNVs the increased densities of all genes, and in
particular ‘‘adaptive genes’’ exhibiting elevated coding
sequence divergence, provide evidence of advantageous
duplications that have yet to become fixed in the human
population.
Materials and Methods
We obtained 823 human CNVs from the Database of Genomic
Variants (http://projects.tcag.ca/variation [version June 2005]) that
had been mapped to the human genome assembly (National Center
for Biotechnology Information Build 35). These CNVs correspond
mainly to those identified by Sebat et al. [3], Iafrate et al. [2], Tuzun et
al. [4], and Sharp et al. [5]. Overlapping CNVs were merged, resulting
in 627 distinct CNV regions. Among these CNV regions, those
identified by two or more independent studies were subclassified as
‘‘frequent,’’ while those observed once were designated as ‘‘rare.’’
CNV regions were also partitioned into those that were duplicated
(‘‘gains’’) or else deleted (‘‘losses’’) on the basis of information
reported in the Database of Genomic Variants. It should be noted
however that assignment of gain or loss is entirely dependent on the
control used for the experiment.
Gene predictions and corresponding Gene Ontology (GO) and GO
Slim (http://www.geneontology.org/GO.slims.shtml) terms, signal pep-
tide [52], human disease association (via the Morbid Map subset of the
Mendelian Inheritance in Man Database [53]), and protein family
annotations were assigned to CNVs according to Ensembl [54]
(Ensembl mart version 31). A similar procedure was used for 346
mouse BACs known to be variable in copy number among 14 mouse
strains [6] that had been mapped to the mouse genome assembly
(National Center for Biotechnology Information Build 30). Gene
predictions for genes within these CNVs were obtained from Ensembl
(Ensembl mart version 19.1). Single orthologues in human and mouse
were taken from a previous study [55]. A total of 13,111 Ensembl
mouse genes possessed single orthologues in human, whereas 13,357
Ensembl human genes possessed single mouse orthologues. (The small
discrepancy between these orthologue counts arises from gene
predictions discarded between different Ensembl versions.) Genes
were considered paralogous if they possessed the same Ensembl
family identifier.
Simple tandem repeats (from Tandem Repeats Finder [28]), SNPs
(from dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP), RNA genes
(microRNAs and small nucleolar RNA), CpG islands, G þ C content,
interspersed repeats, and telomeric or centromeric locations were
obtained from the University of California Santa Cruz’s genome
browser [56] (http://genome.cse.ucsc.edu; human: hg17, mouse: mm3).
Gene expression data (GNF Expression Atlas 2 data for human [57]
and for mouse [58]) were used to define tissue-specific genes (i.e.,
genes possessing at least a 4-fold-higher expression level in one or
more tissues relative to the median expression in all tissues) and also
genes highly expressed in particular tissues (i.e., those where the
average difference (AD) between sense tags and missense tags exceeds
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200). KA and KS values and their ratios were calculated for 1:1
orthologues using the yn00 method of Yang and Nielsen [59].
To test the null hypothesis that a property is higher, or lower, in
known CNVs than elsewhere in the genome, we performed a
randomisation test. For this, 10,000 sets of regions were sampled
randomly from the genome assembly; these regions were matched in
both number and size to the CNV set. This test assumes that the set of
CNVs we considered is representative of all CNVs present in the
human population. We calculated the fraction p of such randomly
chosen regions that contained higher, or lower, values of the
property. Values of p . 0.05 were considered to indicate that the
CNV data were not significantly different from the genome data
taken as a whole.
The likelihood that a GO annotation is over- or underrepresented
amongCNVgenes was estimatedusing the hypergeometric distribution
[60]. The probability that two sets ofKA, KS,orKA/KS values are sampling
an equivalent distribution was calculated using the two-sided Kolmo-
gorov-Smirnov test [61]. The likelihood that CNVs are overrepresented
in regions close to telomeres or centromeres was estimated by fitting to
a Gaussian distribution (using Origins 7.5 software from OriginLab,
Northampton, Massachusetts, United States).
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